Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1304
Selected: 0
NCT IDTitle
NCT00369226Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
NCT06803875Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
NCT06463457Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
NCT00165334Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
NCT01579552Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
NCT00658411Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
NCT00004164Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
NCT00357500Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
NCT01207492Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
NCT02335671Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
NCT02576444OLAParib COmbinations
NCT00136396Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
NCT04406272VB-111 in Surgically Accessible Recurrent/Progressive GBM
NCT00675831Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
NCT03436654Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT05866887Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
NCT02425904Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
NCT04584255Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT02523040Lenalidomide for Adult Histiocyte Disorders
NCT00424723Pemetrexed in Patients With Advanced Neuroendocrine Tumors
NCT04299191Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
NCT02658396GO-203-2C + Bortezomib For Relapsed Or Refractory MM
NCT00005096Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00146562Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
NCT04421560Pembrolizumab, Ibrutinib and Rituximab in PCNSL
NCT00455624Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT04653246Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
NCT02244463A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer
NCT00069940Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
NCT00496665ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
NCT06450171Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
NCT01221753Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT03716180DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
NCT00005627Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00378105Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
NCT00916162Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy
NCT05726370Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
NCT01173523Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer
NCT06055296Multisite Implementation of COMPRENDO
NCT00116220Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
NCT06644183Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
NCT00954720Observational Study of Iron Overload in Stem Cell Transplantation
NCT05463796InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
NCT01741753BKM120+Abiraterone Acetate for Metastatic CRPC
NCT02976103Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket
NCT05701488SIRT With Tremelimumab and Durvalumab for Resectable HCC
NCT00426205GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
NCT04368130SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care
NCT02195232Cancer Associated Thrombosis and Isoquercetin (CATIQ)
NCT01066663Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma